These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25646118)

  • 1. Global HIV funding and local contexts.
    Devnani M; Gupta AK; Guo Y
    Health Aff (Millwood); 2015 Feb; 34(2):359. PubMed ID: 25646118
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV/AIDS. The great funding surge.
    Cohen J
    Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
    [No Abstract]   [Full Text] [Related]  

  • 3. How a new funding model will shift allocations from the Global Fund to Fight AIDS, tuberculosis, and malaria.
    Fan VY; Glassman A; Silverman RL
    Health Aff (Millwood); 2014 Dec; 33(12):2238-46. PubMed ID: 25392001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical funding for HIV/AIDS: 3 caveats.
    Van Puymbroeck RV
    Health Aff (Millwood); 2010 Feb; 29(2):333; author reply 333. PubMed ID: 20348083
    [No Abstract]   [Full Text] [Related]  

  • 5. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries.
    Resch S; Ryckman T; Hecht R
    Lancet Glob Health; 2015 Jan; 3(1):e52-61. PubMed ID: 25539970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring disparities between global HIV/AIDS funding and recent tsunami relief efforts: an ethical analysis.
    Christie T; Asrat GA; Jiwani B; Maddix T; Montaner JS
    Dev World Bioeth; 2007 Apr; 7(1):1-7. PubMed ID: 17355326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the global economic crisis on HIV and AIDS programmes directed at women and children in Zambia.
    Serieux J; Njelesani M; Chompolola A; Sepehri A; Guliani H
    Afr J AIDS Res; 2015; 14(2):95-106. PubMed ID: 26223326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development assistance for health: past trends, associations, and the future of international financial flows for health.
    Dieleman JL; Schneider MT; Haakenstad A; Singh L; Sadat N; Birger M; Reynolds A; Templin T; Hamavid H; Chapin A; Murray CJ
    Lancet; 2016 Jun; 387(10037):2536-44. PubMed ID: 27086170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has HIV/AIDS displaced other health funding priorities? Evidence from a new dataset of development aid for health.
    Lordan G; Tang KK; Carmignani F
    Soc Sci Med; 2011 Aug; 73(3):351-5; discussion 356-8. PubMed ID: 21745705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global health development assistance remained steady in 2013 but did not align with recipients' disease burden.
    Dieleman JL; Graves CM; Templin T; Johnson E; Baral R; Leach-Kemon K; Haakenstad AM; Murray CJ
    Health Aff (Millwood); 2014 May; 33(5):878-86. PubMed ID: 24714869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of HIV/AIDS on economic growth and human capitals: a panel study evidence from Asian countries.
    Roy S
    AIDS Care; 2014; 26(12):1568-75. PubMed ID: 24983845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Funding HIV-vaccine research in developing countries-what is wrong with IAVI's recommendation?
    Sonntag D
    Health Econ; 2014 Feb; 23(2):141-58. PubMed ID: 23355491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimensions of the World Bank's history as a political, intellectual, and financial actor.
    Pereira JMM
    Cad Saude Publica; 2018 Mar; 34(2):e00000118. PubMed ID: 29513822
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of HIV/AIDS on Gross Domestic Product (GDP) in the WHO Africa Region.
    Kirigia JM; Sambo LG; Okorosobo T; Mwabu GM
    Afr J Health Sci; 2002; 9(1-2):27-39. PubMed ID: 17298143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the assessment and attribution of effects of development assistance for health.
    Ataya N; Aluttis C; Flahault A; Atun R; Haines A
    Lancet; 2014 Dec; 384(9961):2256-9. PubMed ID: 24973810
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementation effects of GFATM-supported HIV/AIDS projects on the health sector, civil society and affected communities in Peru 2004-2007.
    Cáceres CF; Girón JM; Sandoval C; López R; Valverde R; Pajuelo J; Vásquez P; Rosasco AM; Chirinos A; Silva-Santisteban A
    Glob Public Health; 2010; 5(3):247-65. PubMed ID: 20390630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Global Financing Facility: country investments for every woman, adolescent, and child.
    Desalegn H; Solberg E; Kim JY
    Lancet; 2015 Jul; 386(9989):105-6. PubMed ID: 26194379
    [No Abstract]   [Full Text] [Related]  

  • 18. Has donor prioritization of HIV/AIDS displaced aid for other health issues?
    Shiffman J
    Health Policy Plan; 2008 Mar; 23(2):95-100. PubMed ID: 18156161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.
    Beck EJ; Santas XM; Delay PR
    AIDS; 2008 Jul; 22 Suppl 1():S75-85. PubMed ID: 18664958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who should pay for global health, and how much?
    Carrasco LR; Coker R; Cook AR
    PLoS Med; 2013; 10(2):e1001392. PubMed ID: 23431273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.